Medrx Co., Ltd.
4586株式会社メドレックス
Latest half-year results
First half · fiscal year to 2026-12 · filed 2026-08-07For the first half of the fiscal year to 2026-12: Revenue ¥0 billion (-37.7% YoY), Ordinary income ¥-0.6 billion, Net income ¥-0.6 billion.
| This period | Year on year | |
|---|---|---|
| Revenue | ¥12m | -37.7% |
| Ordinary profit | −¥554m | — |
| Net profit to owners | −¥551m | — |
From the securities report on EDINET, which states no forecast. History via /v1/companies/4586/earnings-releases.
Financials
Japan GAAP · consolidated · fiscal year to 2025-12-31- Revenue
- ¥128m
- Net income
- −¥937m
- ROE
- —
- Equity ratio
- 92.2%
- Dividend / share
- —
- Employees
- 21
| Fiscal year | Revenue | Net income | Total assets | Net assets | ROE | EPS | Operating CF |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | ¥128m | −¥937m | ¥2,158m | ¥2,049m | — | ¥-17.44 | −¥888m |
| 2024-12-31 | ¥258m | −¥807m | ¥2,276m | ¥2,170m | — | ¥-18.56 | −¥803m |
| 2023-12-31 | ¥30m | −¥933m | ¥2,052m | ¥1,925m | — | ¥-26.82 | −¥914m |
| 2022-12-31 | ¥59m | −¥1,111m | ¥1,398m | ¥1,213m | — | ¥-43.81 | −¥1,073m |
| 2021-12-31 | ¥8m | −¥1,060m | ¥2,109m | ¥1,955m | — | ¥-49.62 | −¥924m |
Indicators
Computed by us from filings · fiscal year to 2025-12-31| Metric | Value | Percentile among listed companies |
|---|---|---|
| ROE, % | — | — |
| Ordinary margin | -7.3191 | 0.3 |
| Equity ratio, % | 92.2 | 99.3 |
| Revenue growth | -0.5034 | 0.6 |
| Net income growth | -0.1619 | 24.9 |
| Operating cash flow / assets | -0.4116 | 1 |
Via /v1/companies/4586/indicators. Descriptive figures, not a rating and not investment advice.
From other filings
As the company states themSegments, votes and tender offers
Stated in EDINET filings/v1/companies/4586/votingOwnership changes
All companies →- 2026-11-02
Growth Capital Inc. reduced holdings in Medrx Co., Ltd. (4586) to 5.41% from 6.15%.
- 2026-10-07
Growth Capital Inc. reduced holdings in Medrx Co., Ltd. (4586) to 6.15% from 8.54%.
- 2026-09-29
Growth Capital Inc. reduced holdings in Medrx Co., Ltd. (4586) to 8.54% from 9.55%.
- 2026-09-15
Growth Capital Inc. reduced holdings in Medrx Co., Ltd. (4586) to 9.55% from 10.77%.
- 2026-09-15
Holdings of Growth Capital Inc. in Medrx Co., Ltd. (4586) moved below 10% (10.77% -> 9.55%).
- 2026-09-02
Growth Capital Inc. filed a correction to a 5% report on Medrx Co., Ltd. (4586).
- 2026-09-02
Growth Capital Inc. filed a correction to a 5% report on Medrx Co., Ltd. (4586).
- 2026-09-02
Growth Capital Inc. filed a correction to a 5% report on Medrx Co., Ltd. (4586).
- 2026-09-02
Growth Capital Inc. filed a correction to a 5% report on Medrx Co., Ltd. (4586).
- 2026-08-31
Growth Capital Inc. reduced holdings in Medrx Co., Ltd. (4586) to 10.77% from 11.90%.
Trades by 5% holders
From the 60-day trade tables in 5% reports| Holder | Period | Net shares | Net % of shares | Avg. filed price | Range |
|---|---|---|---|---|---|
| グロース・キャピタル株式会社 | 2026-06-05 – 2026-10-26 | +3,326,300 | +4.50pt | ¥58 | ¥58–58 |
| Long Corridor Asset Management Limited | 2025-04-03 – 2025-08-20 | +2,740,000 | +4.83pt | ¥69.07 | ¥65–71 |
| Evo Fund | 2022-08-22 – 2024-08-28 | +1,367,800 | +3.61pt | ¥115.59 | ¥92–186 |
| Evolution Capital Management LLC | 2023-06-27 – 2024-08-28 | -1,792,100 | −5.25pt | ¥119.55 | ¥97–184 |
| individual filer | 2022-03-11 – 2024-06-07 | +2,800,000 | +7.63pt | — | — |
| Evolution Japan Asset Management Co., Ltd. | 2022-08-22 – 2023-06-27 | +3,159,900 | +8.85pt | ¥114.39 | ¥92–186 |
Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/4586/trades.
5% filings
Large shareholding reports on 4586| Filed | Filer | Stake | Change | Stated purpose |
|---|---|---|---|---|
| 2026-11-02 | Growth Capital Inc. | 5.41% | −0.74pt | pure investment |
| 2026-10-07 | Growth Capital Inc. | 6.15% | −2.39pt | pure investment |
| 2026-09-29 | Growth Capital Inc. | 8.54% | −1.01pt | pure investment |
| 2026-09-15 | Growth Capital Inc. | 9.55% | −1.22pt | pure investment |
| 2026-09-02 | Growth Capital Inc. | 15.99% | −1.36pt | pure investment |
| 2026-09-02 | Growth Capital Inc. | 15.04% | −0.95pt | pure investment |
| 2026-09-02 | Growth Capital Inc. | 13.70% | −1.34pt | pure investment |
| 2026-09-02 | Growth Capital Inc. | 11.90% | −1.80pt | pure investment |
| 2026-08-31 | Growth Capital Inc. | 10.77% | −1.13pt | pure investment |
| 2026-08-13 | Growth Capital Inc. | 11.90% | −1.80pt | pure investment |
Cross-shareholdings
From the annual report's status of shareholdings- Listed strategic holdings
- — issues
- Book value
- —
- Sold in the year
- — — issues
- Bought in the year
- — — issues
- Mutual, both reports
- 0
- Held by listed cos.
- 1
Held by: KANEKA CORPORATION 4118
Purposes, all holdings and mutual flags via /v1/companies/4586/cross-holdings. Share changes include stock splits.
Major shareholders
As of fiscal year end 2025-12-31| Shareholder | Shares | Ratio |
|---|---|---|
| individual holder | 2,250,000 | 3.79% |
| 楽天証券株式会社 | 2,072,100 | 3.49% |
| individual holder | 2,000,000 | 3.37% |
| 株式会社ＳＢＩ証券 | 1,091,906 | 1.84% |
| 野村證券株式会社 | 803,184 | 1.35% |
| NOMURA PB NOMINEES LIMITED OMNIBUS-MARGIN (CASHPB) | 733,800 | 1.24% |
| 株式会社ＭＭ | 540,300 | 0.91% |
| individual holder | 386,600 | 0.65% |
| individual holder | 373,000 | 0.63% |
| individual holder | 342,600 | 0.58% |
Get this as JSON
GET /v1/companies/4586
GET /v1/companies/4586/financials
GET /v1/companies/4586/details
GET /v1/companies/4586/segments
GET /v1/companies/4586/voting
GET /v1/companies/4586/tender-offers
GET /v1/companies/4586/indicators
GET /v1/companies/4586/earnings-releases
GET /v1/events?ticker=4586
GET /v1/companies/4586/trades
GET /v1/companies/4586/cross-holdings
GET /v1/companies/4586/brief